LC Virtual Symposium


Please join us for the 2021 DF/HCC Lung Cancer Program’s Annual Symposium.


Lung Cancer Screening and Early Detection

With presentations by:


"Circulating Tumor DNA Analysis for Detection and Monitoring of Early Stage Lung Cancer"

Max Diehn, MD, PhD 
CRK Faculty Scholar and Associate Professor
Division Chief of Radiation and Cancer Biology & Vice Chair of Research
Department of Radiation Oncology
Stanford University School of Medicine


"Lung Cancer Screening: Current State and Future Imperatives Towards Reducing Disparities"

Ella A. Kazerooni, MD, MS 
Professor of Radiology & Pulmonary and Critical Care Medicine, University of Michigan Medical School
Associate Chief Clinical Officer, Diagnostic and Clinical Information Oversight Team, University of Michigan Medical Group
Chair, National Lung Cancer Roundtable, American Cancer Society


Panel: Deploying Smoking Cessation and Lung Cancer Early Detection in Diverse Populations

Christopher Lathan, MD, MS, MPH  
Chief Clinical Access and Equity Officer, Dana-Farber Cancer Institute
Associate Medical Director, Dana-Farber Cancer Institute Network
Assistant Professor of Medicine, Harvard Medical School


"Patient Navigation to Screen for Lung Cancer in Community Health Centers’ Current Smokers Randomized Control Trial"

Sanja Percac-Lima, MD, PhD, MPH 
Associate Professor of Medicine, Harvard Medical School
Physician, Medicine, Massachusetts General Hospital


"Reaching the Hardly Reached: Tobacco Control and the Underserved"

Vish Viswanath, PhD 
Lee Kum Kee Professor of Health Communication
Director, Harvard Chan India Research Centre
Director, Harvard Chan/DFCI Center for Translational Communication Science
Co-Director, Lee Kum Sheung Center for Health and Happiness


"Panel: Deploying Smoking Cessation and Lung Cancer Early Detection in Diverse Populations"

Erica T. Warner, ScD, MPH 
Assistant Professor of Medicine, Harvard Medical School
Assistant Investigator, Massachusetts General Hospital